We are live on ! Find out more
TAF

Tredje AP-fonden Portfolio holdings

AUM $22.1B
1-Year Est. Return 41.68%
This Fund
S&P 500
This Quarter Est. Return
+13%
1 Year Est. Return
+41.68%
3 Year Est. Return
+127.87%
5 Year Est. Return
+164.02%
10 Year Est. Return
+659.26%
AUM
$8.01B
AUM Growth
+$1.23B
Cap. Flow
+$393M
Cap. Flow %
4.9%
Top 10 Hldgs %
32.59%
Holding
557
New
21
Increased
181
Reduced
226
Closed
40

Top Buys

Rank Stock Value
1
MCHP icon
Microchip Technology
MCHP
+$56.2M
2
MS icon
Morgan Stanley
MS
+$45.4M
3
NVDA icon
NVIDIA
NVDA
+$38.2M
4
AMZN icon
Amazon
AMZN
+$37.1M
5
MSFT icon
Microsoft
MSFT
+$22.1M

Sector Composition

Rank Sector Weight
1 Technology 30.64%
2 Healthcare 14.83%
3 Financials 12.74%
4 Consumer Discretionary 11.83%
5 Communication Services 10.21%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
FE icon
276
FirstEnergy
FE
$27.2B
$3.16M 0.04%
86,238
-3,587
-4% -$130K
REG icon
277
Regency Centers
REG
$13.9B
$3.16M 0.04%
47,141
-479
-1% -$29.6K
ZS icon
278
Zscaler
ZS
$28.6B
$3.14M 0.04%
14,185
-261
-2% -$48.3K
DRI icon
279
Darden Restaurants
DRI
$25.1B
$3.13M 0.04%
19,049
-910
-5% -$138K
GRMN
280
Garmin
GRMN
$59.7B
$3.12M 0.04%
24,250
-1,004
-4% -$116K
BAX icon
281
Baxter International
BAX
$14B
$3.1M 0.04%
80,177
-3,263
-4% -$115K
WAT icon
282
Waters Corp
WAT
$40.8B
$3.08M 0.04%
9,358
-381
-4% -$105K
AFL icon
283
Aflac
AFL
$60.8B
$3.08M 0.04%
37,334
-189,161
-84% -$15.2M
VRSN icon
284
VeriSign
VRSN
$25.6B
$3.07M 0.04%
+14,882
New +$3.1M
EXPD icon
285
Expeditors International
EXPD
$23.5B
$3.06M 0.04%
24,079
-1,143
-5% -$135K
RPRX icon
286
Royalty Pharma
RPRX
$26.2B
$3.05M 0.04%
108,406
PFG icon
287
Principal Financial Group
PFG
$24.2B
$3.01M 0.04%
38,269
-778
-2% -$56.3K
CAG icon
288
Conagra Brands
CAG
$7.16B
$2.97M 0.04%
103,778
+25,038
+32% +$702K
COO icon
289
Cooper Companies
COO
$14.8B
$2.97M 0.04%
31,364
-2,148
-6% -$180K
CCL icon
290
Carnival Corporation Ltd
CCL
$38B
$2.96M 0.04%
159,512
-6,762
-4% -$98.2K
UDR icon
291
UDR
UDR
$12B
$2.95M 0.04%
77,081
-877
-1% -$30.5K
CBOE icon
292
Cboe Global Markets
CBOE
$30B
$2.94M 0.04%
16,487
-940
-5% -$161K
WBA
293
DELISTED
Walgreens Boots Alliance
WBA
$2.93M 0.04%
+112,293
New +$2.51M
NTAP icon
294
NetApp
NTAP
$39.1B
$2.91M 0.04%
33,057
-2,010
-6% -$162K
NUE icon
295
Nucor
NUE
$61.5B
$2.9M 0.04%
16,675
AKAM icon
296
Akamai
AKAM
$17.8B
$2.88M 0.04%
24,366
-1,522
-6% -$169K
CFG icon
297
Citizens Financial Group
CFG
$31B
$2.87M 0.04%
86,711
-322
-0.4% -$8.86K
BMRN icon
298
BioMarin Pharmaceuticals
BMRN
$13.7B
$2.87M 0.04%
29,793
-1,185
-4% -$105K
FCNCA icon
299
First Citizens BancShares
FCNCA
$25.6B
$2.86M 0.04%
2,015
+50
+3% +$70.2K
CNP icon
300
CenterPoint Energy
CNP
$26.7B
$2.86M 0.04%
99,933
-4,225
-4% -$117K

Similar funds

Tredje AP-fonden's Q4 2023 Portfolio in Review

As of Q4 2023, Tredje AP-fonden held 557 positions worth $8.01B, up 18% from $6.78B the previous quarter. Its ten largest holdings account for 33% of the portfolio.

Tredje AP-fonden deployed $393M of net new capital in Q4 2023, opening 21 new positions and adding to 181 existing holdings. Its largest new stake was Capital One: 190,000 shares worth $24.9M.

By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 29% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was Regeneron Pharmaceuticals, an estimated $35.8M trimmed.

  • Tredje AP-fonden's largest Q4 2023 buy was Capital One: 190,000 shares worth $24.9M.
  • Tredje AP-fonden added most to Microchip Technology in Q4 2023, an estimated $56.2M increase.
  • Tredje AP-fonden's biggest Q4 2023 reduction was Regeneron Pharmaceuticals, cutting an estimated $35.8M.
  • Tredje AP-fonden fully exited Activision Blizzard in Q4 2023, selling an estimated $13.6M.
  • Tredje AP-fonden's ten largest holdings make up 33% of its $8.01B portfolio in Q4 2023.
  • Tredje AP-fonden opened 21 new positions and closed 40 in Q4 2023.
  • Tredje AP-fonden's portfolio value rose 18% quarter-over-quarter to $8.01B.

Based on Tredje AP-fonden's 13F filing for Q4 2023, filed 12 Feb 2024.